ESR1 and breast cancer: The underlying mechanism involves activation of PRODH/POX (by PPAR-γ ligand, TGZ) that under availability of proline (substrate for PRODH/POX) and dependently on the ER status (absence of estradiol or ERβ) induces apoptosis in ER negative breast cancer cells.